- Nausea and vomiting prevention and treatment
- Allergic rhinitis and other allergic conditions
- Motion sickness prevention
- Sedation (preoperative and postoperative)
- Adjunct in anaphylaxis treatment
Promethazine
Generic Name: Promethazine
Brand Names: Phenergan
Promethazine is a first-generation antihistamine with antiemetic, sedative, and antihistamine properties.
Drug Class
First-Generation Phenothiazine Antihistamine (H1 Antagonist) with Antiemetic and Sedative Properties
Pregnancy
Category C — Animal studies have shown adverse effects at high doses. Limited human data have not consistently demonstrated teratogenicity, but use near term may cause neonatal sedation, hypotonia, or extrapyramidal symptoms. Reserve for situations where benefit clearly outweighs risk; ondansetron or doxylamine-pyridoxine are preferred for pregnancy-associated nausea.
Available Forms
Oral tablet (12.5 mg, 25 mg, 50 mg), Oral syrup (6.25 mg/5 mL), Rectal suppository (12.5 mg, 25 mg, 50 mg), Injection for IM or deep IV use (25 mg/mL, 50 mg/mL — IV use carries FDA Boxed Warning for severe tissue injury)
What It's Used For
Dosage Quick Reference
These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.
| Condition | Starting Dose | Maintenance Dose |
|---|---|---|
| Nausea and vomiting (adult) | 12.5–25 mg orally, rectally, or IM every 4–6 hours as needed | Same dose; reassess after 24 hours |
| Allergic rhinitis or urticaria (adult) | 12.5 mg before meals and at bedtime | 25 mg at bedtime if needed |
| Motion sickness (adult) | 25 mg orally 30–60 minutes before travel | 25 mg every 8–12 hours during travel |
| Preoperative or postoperative sedation | 25–50 mg IM | Repeat every 4–6 hours as needed |
| Pediatric (>= 2 years; nausea, allergy) | 0.25–0.5 mg/kg per dose every 4–6 hours | Use lowest effective dose; max 25 mg/dose |
Side Effects
Common Side Effects:
- Drowsiness and sedation
- Dizziness
- Dry mouth
- Blurred vision
- Constipation
- Confusion (especially in elderly)
- Urinary retention
Serious Side Effects (seek immediate medical attention):
- Severe respiratory depression (especially in children)
- Severe tissue injury at injection site
- Neuroleptic malignant syndrome (fever, rigidity, altered consciousness)
- Severe hypotension
- Seizures
- Extrapyramidal symptoms (involuntary movements)
Drug Interactions
Promethazine has wide receptor activity (H1, dopamine D2, muscarinic, alpha-adrenergic) which produces both pharmacodynamic and pharmacokinetic interactions of concern.
- CNS depressants (opioids, benzodiazepines, alcohol, sedating antihistamines, gabapentin, sleep aids): Profound additive sedation and respiratory depression. The FDA has highlighted risk when combined with opioids; use the lowest effective dose and avoid combining with other sedating agents whenever possible.
- Anticholinergic agents (oxybutynin, tricyclic antidepressants, diphenhydramine, scopolamine): Additive dry mouth, urinary retention, blurred vision, constipation, confusion, and anticholinergic delirium — especially in older adults.
- Dopamine antagonists (haloperidol, metoclopramide, prochlorperazine): Additive risk of extrapyramidal symptoms, akathisia, and neuroleptic malignant syndrome.
- MAO inhibitors: May intensify and prolong promethazine anticholinergic effects and contribute to hypotension. Use cautiously and at reduced doses.
- Epinephrine: Promethazine alpha-adrenergic blockade can cause paradoxical further fall in blood pressure when epinephrine is given in shock. Use norepinephrine or phenylephrine in patients on phenothiazines.
- QT-prolonging agents (e.g., ondansetron, methadone, amiodarone, ciprofloxacin): Additive QT prolongation. Obtain ECG and monitor electrolytes when combinations are unavoidable.
Additional Information
Promethazine is a first-generation antihistamine with additional antiemetic, sedative, and anticholinergic properties. Originally developed as an antihistamine, it has found widespread use for prevention and treatment of nausea and vomiting, as a sedative, and as an adjunct in pain management. Its versatility makes it valuable in multiple clinical settings, though safety considerations limit its use in certain populations.
Mechanism of Action
Promethazine exerts its effects through multiple receptor interactions. As a histamine H1 receptor antagonist, it blocks the effects of histamine on capillaries, bronchial smooth muscle, and the gastrointestinal tract. Its antiemetic effect results primarily from blocking H1 receptors and muscarinic receptors in the vomiting center and chemoreceptor trigger zone. The sedative effects are mediated through central H1 blockade. Promethazine also has significant anticholinergic activity and weak antidopaminergic properties, contributing to both therapeutic effects and side effects.
The medication has local anesthetic properties due to its membrane-stabilizing effects, which may contribute to its ability to relieve itching and irritation associated with allergic reactions.
Available Formulations
Promethazine (Phenergan) is available in multiple formulations including oral tablets (12.5 mg, 25 mg, 50 mg), oral solution (6.25 mg/5 mL), suppositories (12.5 mg, 25 mg, 50 mg), and injectable solution (25 mg/mL, 50 mg/mL) for deep intramuscular or intravenous use. The variety of formulations allows administration even when nausea prevents oral intake. Combination products with codeine (Phenergan with Codeine) are available for cough suppression.
FDA-Approved Indications
Promethazine is FDA-approved for allergic conditions (perennial and seasonal allergic rhinitis, allergic conjunctivitis, uncomplicated allergic skin manifestations of urticaria and angioedema), prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery, therapy adjunct in anaphylactic reactions (after acute symptoms controlled with epinephrine), preoperative, postoperative, or obstetric sedation, and prevention and treatment of motion sickness.
Dosing Guidelines
For allergic conditions, the typical adult dose is 25 mg orally at bedtime, or 12.5 mg before meals and at bedtime. For nausea and vomiting, 12.5-25 mg every 4-6 hours as needed is typical. For sedation, 25-50 mg at bedtime or preoperatively. For motion sickness, 25 mg 30-60 minutes before travel, repeated every 8-12 hours as needed. Doses should be reduced in elderly patients and those with hepatic impairment.
Boxed Warning for Respiratory Depression in Children
Promethazine carries a boxed warning contraindicated in children less than 2 years of age due to the potential for fatal respiratory depression. In children 2 years and older, use the lowest effective dose and avoid combination with other respiratory depressants. Promethazine should not be used for treatment of uncomplicated vomiting in children; use should be limited to prolonged vomiting of known etiology.
Important Safety Considerations
Beyond the pediatric concerns, promethazine causes significant sedation and impairs mental and physical abilities required for tasks such as driving. Anticholinergic effects include dry mouth, urinary retention, constipation, and blurred vision. The medication can lower the seizure threshold and should be used cautiously in patients with seizure disorders. Neuroleptic malignant syndrome has been reported. Avoid concurrent use with other CNS depressants including opioids, sedatives, and alcohol.
Injection Site Concerns
Intravenous administration of promethazine has been associated with severe tissue injury including gangrene requiring amputation. The preferred route is deep intramuscular injection. If IV administration is necessary, it should be given through a running IV line at the port furthest from the patient's vein, at a concentration no greater than 25 mg/mL, at a rate not exceeding 25 mg/minute. Subcutaneous and intra-arterial injection are contraindicated.
Drug Interactions
CNS depressants (opioids, benzodiazepines, alcohol) have additive effects and may cause profound sedation or respiratory depression. Anticholinergic drugs increase the risk of adverse effects. MAO inhibitors may prolong and intensify anticholinergic effects. Promethazine may enhance the hypotensive effects of antihypertensive agents. It may interfere with pregnancy tests and glucose tolerance tests.
Learn more at MedlinePlus
Frequently Asked Questions
Questions to Ask Your Doctor
Consider discussing these topics at your next appointment:
- ✓Is promethazine the safest option for my symptoms, or would another antiemetic or antihistamine be better?
- ✓Could any of my current medications interact with promethazine to cause sedation or heart rhythm problems?
- ✓How long should I plan to take promethazine, and what symptoms should prompt me to stop?
- ✓If I am over 65 or care for an older adult, are there safer alternatives I should consider?
Related Health Conditions
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Related Articles
Questions About This Medication?
Talk to your doctor or pharmacist about whether Promethazine is right for you.
Contact UsCall: (727) 820-7800